跳转至内容
Merck
CN
  • Hypersensitivity response has negligible impact on Hematopoietic Stem Cells.

Hypersensitivity response has negligible impact on Hematopoietic Stem Cells.

Stem cell reports (2021-07-24)
Nir Bujanover, Roshina Thapa, Oron Goldstein, Leonid Olender, Omri Sharabi, Michael D Milsom, Roi Gazit
摘要

Immune cells are generated from hematopoietic stem cells (HSCs) in the bone marrow (BM). Immune stimulation can rapidly activate HSCs out of their quiescent state to accelerate the generation of immune cells. HSCs' activation follows various viral or bacterial stimuli, and we sought to investigate the hypersensitivity immune response. Surprisingly, the Ova-induced hypersensitivity peritonitis model finds no significant changes in BM HSCs. HSC markers cKIT, SCA1, CD48, CD150, and the Fgd5-mCherry reporter showed no significant difference from control. Functionally, hypersensitivity did not alter HSCs' potency, as assayed by transplantation. We further characterized the possible impact of hypersensitivity using RNA-sequencing of HSCs, finding minor changes at the transcriptome level. Moreover, hypersensitivity induced no significant change in the proliferative state of HSCs. Therefore, this study suggests that, in contrast to other immune stimuli, hypersensitivity has no impact on HSCs.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
脱氧核糖核酸酶 I 来源于牛胰腺, Type IV, lyophilized powder, ≥2,000 Kunitz units/mg protein
Sigma-Aldrich
5-溴-2′-脱氧尿苷, ≥99% (HPLC)
Sigma-Aldrich
聚肌苷酸-聚胞苷酸 钠盐, 10% Poly (I:C) with buffer salts, TLR ligand tested